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Abstract
In patients with type 2 diabetes mellitus (Type 2 DM), glycemic control plays an essential role in reducing macro- 
and microvascular complications. The earliest marker for diabetic nephropathy is the presence of albuminuria. 
Meanwhile, HbA1c  has been recognized as a marker of glycemic control in the blood. This study aimed to identify 
the correlation between HbA1c and albuminuria in type 2 DM. This was a cross-sectional study involving 100 
patients with type 2 DM aged 40–70 years visiting Dr. Soetomo Hospital, Surabaya, Indonesia. Secondary data 
from medical records of type 2 DM patients undergoing HbA1c and albuminuria examinations from January to 
December 2015 were used. The mean age of subjects was 55.4 ±8.7 years, with the majority (55%) being of 
female gender. The mean HbA1c concentration was 9.8±2.4%. Most subjects (83%) had an HbA1c level of ≥7 %. 
Albuminuria was found in the majority of the subjects (78%), where 33% of them had positive 1 albuminuria. 
The Spearman correlation test showed a positive strong significant correlation between HbA1c and albuminuria, 
with r=0.865 and p<0.001. Thus, it can be concluded that there is a significant correlation between HbA1c and 
albuminuria in type 2 DM.
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Korelasi HbA1c dan Albuminuria pada Diabetes Melitus Tipe 2
Abstrak
Pada penderita diabetes melitus tipe 2 (DM tipe 2), kontrol glikemik memegang peranan penting untuk 
menurunkan komplikasi makrovaskular dan mikrovaskular. Petanda awal terjadi nefropati diabetik adalah 
albuminuria. HBA1c merupakan petanda untuk mengetahui kontrol glikemik didalam darah. Tujuan penelitian ini 
untuk mengetahui korelasi antara HbA1c dengan albuminuria pada DM tipe 2. Penelitian ini menggunakan desain 
potong lintang, mengikutsertakan 100 penderita DM tipe 2 berusia 40–70 tahun di Rumah Sakit Dr. Soetomo 
Surabaya. Data yang digunakan adalah data sekunder dari rekam medis penderita DM tipe 2 yang melakukan 
pemeriksaan HbA1c dan albuminuria pada bulan Januari–Desember 2015. Rerata usia subjek adalah 55,47±8,7 
tahun dengan subjek terbanyak berjenis kelamin perempuan (55%). Rerata kadar HbA1c berkisar 9,8±2,4 %. 
Sebagian besar subjek mempunyai kadar HbA1c ≥7% yaitu 83%. Albuminuria dijumpai pada sebagian besar 
subjek, yaitu 78% dan sebagian besar subjek mempunyai albuminuria positif 1, yaitu 33 %. Hasil uji korelasi 
Spearman menunjukkan terdapat korelasi positif kuat yang bermakna antara HbA1c dengan albuminuria dengan 
nilai r=0,865 dan p<0,001. Simpulan, terdapat korelasi yang bermakna antara HbA1c dan albuminuria pada DM 
tipe 2.
Kata kunci : Albuminuria, diabetes melitus tipe 2, HbA1c, nefropati diabetik
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Introduction 
Diabetes Mellitus (DM) is a chronic disease 
caused by the inability of the body to produce 
the insulin hormone or ineffective utilization of 
the produced insulin, which is marked by a high 
blood glucose concentration. The prevalence of 
DM is increasing rapidly, and it is estimated that, 
currently, 8.3% of adults worldwide are suffered 
from DM. The 2014 WHO Global Status Report 
on non-communicable disease (NCD) showed 
that  68% of worldwide mortality for all ages 
is related to NCDs.1 DM ranks sixth as the cause 
of death, with around 1.3 million persons dying 
from DM, and 4% of these deaths occur before 
70 years of age. By the year 2030, it is estimated 
that DM occupies the seventh rank as the cause 
of global mortality. In Indonesia, it is estimated 
that by 2030, there will be 21.3 million patients 
with DM.2,3
The high prevalence of DM in Indonesia 
and its complications, such as retinopathy, 
nephropathy, diabetic gangrene, heart disease, 
and stroke, constitutes a significant threat 
to health development. The relationship 
between DM and end-stage kidney disease has 
been known to be the main result of diabetic 
nephropathy.4 Aggressive glycemic control plays 
an essential role in patients with type 2 DM, 
since it may prevent micro- and macrovascular 
complications of DM. There is evidence that long-
term hyperglycemia may lead to the occurrence 
of  microvascular complications, both in  patients 
with type 1 DM and  type 2 DM.4 
Glycemic variability is a term used to describe 
disturbed glycemic control. Hemoglobin A1c 
(HbA1c) reflects long-term glycemic control 
and may be used for the diagnosis of DM.5 In 
addition to diagnosis, the HbA1c level may be 
used to predict the microvascular complications 
of DM, one of them being diabetic nephropathy. 
Diabetic nephropathy is marked by excessive 
excretion of albumin followed by a decrease in 
renal function.6 
Albuminuria is the characteristic feature of 
diabetic nephropathy. Microalbuminuria is the 
principal early predictor of the development of 
glomerular diabetic nephropathy, and may be 
viewed as a measure of the severity of diabetic 
nephropathy and its development.6 Data from 
the United States showed that the percentage 
of adults with DM who are capable of achieving 
the target of glycemic control  (HbA1c) of <7% 
tends to decrease from 52.2% in 2011 to 50.9% 
in 2014.7 To date there is still a difference in 
opinions concerning the relationship between 
long-term glycemic control  (HbA1c) and the 
occurrence of diabetic nephropathy. The 
study of Showail et al.4 stated that there is a 
significant relationship between uncontrolled 
glycemia and the occurrence of albuminuria. 
On the other hand, the study of Tarigan et al.8 
declared no critical relationship between HbA1c 
concentration and the occurrence of diabetic 
nephropathy in patients with type 2 DM.4,8 The 
present study aimed to determine the correlation 
between HbA1c concentration and albuminuria 
in patients with type 2 DM.
Methods
This was a cross-sectional study conducted 
on 100 subjects based on secondary data 
from medical records in Dr. Soetomo Hospital, 
Surabaya. The inclusion criteria in the present 
study were patients with type 2 DM, aged 40-
70 years, and having HbA1c and albuminuria 
data in the medical records. The HbA1c 
determination was based on the turbidimetric 
inhibition immunoassay for hemolyzed whole 
blood at Cobas C311, whereas the albuminuria 
determination was based on dipstick urinalysis 
using Urisys 2400. Medical record data were 
collected from patients who underwent HbA1c 
and albuminuria examinations from January 
to December 2015. The exclusion criteria were 
incomplete medical records and pregnancy in 
the case of female patients. Glycemic control 
was considered to be good if HbA1c <7%.7  
This study obtained ethical clearance from the 
Ethics Commission of the Faculty of Medicine, 
Trisakti University, under Ethical Clearance no. 
116/KER-FK/X/2015. Data were presented as 
percentage, mean, and standard deviation.  In 
order to determine the relationship between 
HbA1c and albuminuria in type 2 DM, the 
Spearman correlation test was used at a level 
of significance of p<0.05. Chi-Square analysis 
was used to analyze the value of the differences 
between two categorical parameters.
Results
The female and male ratio was 55:45 while the 
average age was 55.47±8.7 years, of which 70% 
were ≤ 60 years and 30% were over 60 years. 
The HbA1c concentration was 9.8±2.4%; and the 
frequency of negative, +1, +2, and +3 albuminuria 
was 22%, 33%, 26%, and 19% respectively 
(Table1).
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Table 1  Subject Characteristics
Characteristic n(%) / X±SD
Gender
       Male




      ≤60





      ˂7





      Negative
      +1
      +2





Table 3 Relationship between Albuminuria, Gender, and Age
Variable n 
 Albuminuria
Negative +1 +2 +3 p-value
Gender
Male 45 12 18 10 5 0.161
Female 55 10 15 16 14
Age (years)
≤60 70 16 26 14 14 0.363
˃60 30 6 7 12 5
Chi Square test; p<0.05 = significant difference








Male 45 10 35 0.209
Female 55 7 48
Age (years)
≤60 70 13 57 0.523
˃60 30 4 26
Chi-Square test; p<0.05 = significant difference
Figure 1 HbA1c Level and Albuminuria Degree
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There was no significant difference in 
glycemic controlled (HbA1c) between different 
genders (p=0.209) and between the elderly 
(>60 years) and younger (≤60 years) groups 
(p=0.523) (Table 2). 
There was higher positive albuminuria cases 
in uncontrolled HbA1c level group with p<0.001 
(Table 4 and Figure 1).
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<7%(controlled) 17 13 4 0,001
≥7% (uncontrolled) 83 9 74
Chi Square test; p<0.05 = significant difference
Figure 2 Correlation between HbA1c and   
   Albuminuria in Type 2 DM
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Discussion 
HbA1c is a measure of glycated hemoglobin that 
estimates the mean blood glucose concentration 
over the erythrocyte life span of 120 days. HbA1c 
is most frequently used to evaluate long-term 
glycemic control  in  patients with DM.9 
The study’s results showed that the subjects 
had a signifying poor glycemic control (Table 
1). As recommended by the American Diabetes 
Association (ADA), HbA1c is said to be controlled 
if it is <7 %. When the level is >7%, the risk of 
both micro- and macrovascular complications 
increases.9  The study of Muraliswaran et al.10 
on subjects aged between 30 to 70 yeas with 
a mean age of 53.98±12.74 years revealed a 
mean HbA1c of 8.48±2.22%. Several factors may 
influence HbA1c concentration, including age. It 
is evident that the higher the age of the subjects 
is, the higher the HbA1c concentration.7,11
In the present study, it was discovered 
that the subjects had the following degrees 
of albuminuria: negative, positive 1, positive 
2, and positive 3, with the highest percentage 
being positive 1 at 33%. The study conducted 
by Muraliswaran et al.10 found a mean 
microalbuminuria concentration of 26.25±13.11. 
A survey performed in a community of white 
adults aged 20–65 years showed a prevalence 
of microalbuminuria of 6.3%.12 In persons aged 
60–74 years, the prevalence increased from 13 
to 20%, so that the prevalence of albuminuria is 
said to increase with advancing age.13
The albuminuria values differ between 
individuals because, in addition to being the 
result of renal disease, it may also be caused by 
vigorous physical activities, dehydration, stress, 
fever, admixture of vaginal mucus, urinary tract 
infection, orthostatic proteinuria, pregnancy, 
thermal damage, and various inflammatory 
processes.14 Patients with DM have a prospect 
of renal damage that is measurable by increased 
urinary excretion of albumin. Albuminuria is 
known as a marker of early onset of renal damage 
and a risk factor for the development of a chronic 
renal disease, which finally leads to the end-stage 
renal disease (ESRD).15 An albumin secretion 
of 30-300 mg/day is termed microalbuminuria, 
with <20 mg/day considered normal.16 
Persistent microalbuminuria is considered an 
early indicator of diabetic nephropathy. Patients 
with type 2 DM and microalbuminuria will face 
increased long-term mortality and increased 
risk of macroalbuminuria. To date, the screening 
method of choice for microalbuminuria is the 
measurement of the albumin-creatinine ratio 
in random urine specimens thus avoiding the 
confounding effect of the variability of urinary 
volume, urinary albumin concentration, and/
or the need for collecting 24-hour urine. With 
the above-mentioned method, an albumin/
creatinine ratio of 30–300 mg/g is equivalent 
to albumin excretion of 30–300 mg/day, 
indicating microalbuminuria. If the excretion 
of albumin/creatinine ratio exceeds 300 
mg/g, macroalbuminuria can be diagnosed.17 
Early detection of albuminuria and risk factor 
assessment may prevent the development of 
diabetic nephropathy.18
In Table 2, it can be seen that the glycemic 
control (HbA1c) is not associated with the 
gender or age of the patient. This statement 
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agrees with the ADA statement that glycemic 
control is affected by various factors including, 
among others, the duration of diabetes, existing 
comorbidities, and vascular complications.11 
Similarly, Table 3 shows that albuminuria is not 
associated with gender or age.  This statement 
is in line with the study of Habib et al.19 that 
concluded albuminuria from renal damage may 
occur at all stages of life, especially in patients 
with type 2 DM with poor glycemic control.  The 
study of Showail et al.4 showed similar results, in 
that the factors of age and gender do not play a 
role in the development of microalbuminuria. 
In the present study, there is higher positive 
albuminuria at uncontrolled HbA1c levels 
with p<0.001 (Table 4 and Figure 1) and the 
correlation between HbA1c and albuminuria 
is significant, with r=0.865 and p<0.001 
(Figure 2). It shows that a significant positive 
correlation between HbA1c and albuminuria 
is present, indicating that the higher the 
HbA1c concentration is, the more severe the 
albuminuria. These results are in agreement 
with those of the study of Muraliswaran et al.10 
that demonstrated a significant correlation 
between HbA1c and albuminuria (r=0.5590 
and p=0.05). Muraliswaran et al.10 obtained 
data from subjects without systemic disease 
such as cardiovascular disease, cerebrovascular 
disease, urinary tract infection, and type 1 DM. 
Other studies with similar results are the studies 
by Showail et al.4, Chiu et al.5, and Kundu et al.20 
showing that poor glycemic control is associated 
with the increasing incidence of albuminuria. 
In conclusion, there is a significant positive 
correlation between HbA1c concentration 
and albuminuria in patients with type 2 DM. 
Uncontrolled HbA1c levels may cause higher 
albuminuria. In patients with type 2 DM, 
achieving satisfactory glycemic control is a must 
to obtain HbA1c concentration target in order 
to prevent or delay the development of renal 
damage. 
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